Menstrual Cycle Cycle Biomarkers

Characteristics of the menstrual cycle after discontinuation of oral contraceptives

Nassaralla CL, Daly KD, Schneider M, Fehring RJ, Stanford JB, Schliep KC

Published February 2011 Journal of Women's Health (2002), 20(2), 169-177
DOI 10.1089/jwh.2010.2001 PMID 21219248 PMC PMC7643763

RRM Academy Synopsis

Mucus quality is lower in cycles 1 and 2 after oral contraceptives end

A retrospective matched cohort of 140 women charting with the Creighton Model FertilityCare System found altered cycle biomarkers after oral contraceptives were stopped. Recent oral contraceptive users had lower mucus quality scores in cycles 1 and 2. Across the first six cycles combined, the estimated day of ovulation was later and menstrual flow intensity was lower.

Key Findings

  • The study compared 70 women who stopped oral contraceptives within 12 weeks with 70 controls, paired by age and parity, who had been free of them for at least 1 year.
  • In the unmatched first-cycle comparison, the mean mucus score was 7.3 in recent users and 9.0 in controls (p = 0.01); matched analyses found significantly lower scores in cycles 1 and 2.
  • The first-cycle mean menstrual flow score was 4.9 in recent users and 6.2 in controls (p = 0.0001), with lower intensity significant through the first four cycles.
  • The estimated day of ovulation was later in recent users in cycle 2 and over six cycles, and cycle length was longer over the six cycles.
  • Satisfaction and confidence with the Creighton Model FertilityCare System did not differ significantly between recent users and controls at the first and sixth follow-up visits.

Interpretation

The study is a retrospective matched cohort. Its data come from charts that women kept daily as they started the Creighton Model FertilityCare System. Random effects modeling compared the groups across up to six cycles per woman. Participants were aged 18 to 42 and had no history of infertility. Two trained professionals independently validated every chart. The authors note that fewer cycles contributed at each later cycle number, which limits the estimates for single cycles.

RRM Context

The Creighton Model FertilityCare System is a natural family planning method in which women record daily observations of bleeding and cervical mucus. The biomarkers in the study were abstracted from those charts. Charting gives restorative reproductive medicine a record of how cycles change after suppressive medications such as oral contraceptives are stopped. An earlier analysis cited in the paper tied a mucus score change of 2 to an absolute change of about 5% in the chance of conception each cycle.

Abstract

Background

Menstrual cycle function may continue to be altered after discontinuation of oral contraceptives (OC). Few studies have been published on the effects of recent OC use on menstrual cycle parameters; none have examined characteristics of the menstrual flow or the quality of cervical mucus. The purpose of this retrospective matched cohort study is to assess biomarkers of the menstrual cycle after discontinuation of OCs.

Methods

Among a sample of women who daily recorded observations of menstrual cycle biomarkers, 70 women who had recently discontinued OCs were randomly matched by age and parity with 70 women who had not used OCs for at least 1 year. Outcomes investigated included overall cycle length, length of the luteal phase, estimated day of ovulation, duration of menstrual flow, menstrual intensity, and mucus score. Differences between recent OC users and controls were assessed using random effects modeling.

Results

Recent OC users had statistically significantly lower scores for mucus quality for cycles 1 and 2. Additionally, OC users had a later estimated day of ovulation that was statistically significant in cycle 2 and a decreased intensity of menstrual flow that was significant in the first four cycles (difference = -0.48 days). In random effects modeling, all these parameters were significantly different for the first six cycles combined.

Conclusions

Menstrual cycle biomarkers are altered for at least two cycles after discontinuation of OCs, and this may help explain the temporary decrease in fecundity associated with recent OC use.

Topics

By this author

Related research

Menstrual Cycle › Cycle Biomarkers › Cervical Mucus · Reproductive Endocrinology › Ovulation Physiology › Follicular Development · Contraception › Oral Contraceptives › Metabolic Effects
Joseph B Stanford, Mary Schneider, Karen C Schliep, Richard J Fehring, K Diane Daly, Claudia L Nassaralla
Joe Stanford, Joey Stanford, J Stanford, M Schneider, K Schliep, Rick Fehring, Dick Fehring, Rich Fehring, R Fehring, C Nassaralla
PMID 21219248 21219248 DOI 10.1089/jwh.2010.2001 10.1089/jwh.2010.2001 Nassaralla et al. 2011, Nassaralla 2011